NCT06799936 A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
| NCT ID | NCT06799936 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Chronic Kidney Disease Stage 4 |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2025-02-04 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2025-02-04 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication principles from VitalTalk and Elwyn's goal-based SDM model. The investigators hypothesize that compared with patients in the usual care group, patients in the 'CKD Jumpstart- Tips' intervention group will have: 1. increased level of shared decision-making (observer-based and patient-reported), 2. improved quality of communication, 3. increased patient involvement in decision-making, 4. lower decisional conflict, 5. lower decision regret, 6. decreased time to decision, 7. improved adherence to treatment choice, and 8. improved health-related quality-of-life.
Eligibility Criteria
Inclusion criteria for the two groups of participants (i.e. Clinicians and Patients): 1. Clinicians \- Nephrology specialists or higher physician trainees who provide specialty care to older adults with advanced chronic kidney disease 2. Patients * Diagnosis of advanced CKD Stage 4 or 5 (eGRF \<30 ml/min) * Chinese- or English-speaking * Identified as patient with whom their clinician plans to discuss advanced kidney disease treatment options in the upcoming clinic visit * Able to provide written informed consent and complete questionnaires * Can be contacted by phone Exclusion criteria for patients: * Patients will be excluded if they are eligible for kidney transplant, currently on dialysis, or lack decision-making capacity
Contact & Investigator
Jacqueline KY Yuen, Dr
PRINCIPAL INVESTIGATOR
The University of Hong Kong
Frequently Asked Questions
Who can join the NCT06799936 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Chronic Kidney Disease Stage 4. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06799936 currently recruiting?
Yes, NCT06799936 is actively recruiting participants. Contact the research team at jkyuen@hku.hk for enrollment information.
Where is the NCT06799936 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06799936 clinical trial?
NCT06799936 is sponsored by The University of Hong Kong. The principal investigator is Jacqueline KY Yuen, Dr at The University of Hong Kong. The trial plans to enroll 280 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.